CALPROTECTIN IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RELATION TO CLINICAL AND LABORATORY VARIABLES OF DISEASE-ACTIVITY

被引:1
作者
BRUN, JG
HAGA, HJ
BOE, E
KALLAY, I
LEKVEN, C
BERNTZEN, HB
FAGERHOL, MK
机构
[1] OSLO SANITETSFORENING REUMATISM HOSP, OSLO, NORWAY
[2] ULLEVAL HOSP, DEPT IMMUNOL, OSLO 1, NORWAY
[3] ULLEVAL HOSP, BLOOD BANK, OSLO 1, NORWAY
关键词
RHEUMATOID ARTHRITIS; DISEASE ACTIVITY; CALPROTECTIN; L1; PROTEIN; C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION RATE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calprotectin (L1) is a major granulocyte and monocyte protein which is released during activation of these cells. The plasma level of L1 is thought to reflect disease activity in rheumatoid arthritis (RA). In our cross sectional study of 70 patients with RA, L1 had significant correlations with erythrocyte sedimentation rate (r=0.50), C-reactive protein (r=0.58), orosomucoid (r=0.62), platelet count (r=0.42), leukocyte count (r=0.33) and IgM rheumatoid factor (r=0.32); and with the following clinical variables: number of swollen joints (r=0.24), grip strength (r = -0.22), PIP joint circumferences (r=0.33) and a combined global assessment score (r = 0.24). L1 was higher in seropositive (median 14,861-mu-g/I) than seronegative patients (median 10,487-mu-g/l) (p < 0.03).
引用
收藏
页码:859 / 862
页数:4
相关论文
共 31 条
[21]   ANALYSIS OF IMPROVEMENT IN INDIVIDUAL RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BASED ON THE FINDINGS IN PATIENTS TREATED WITH PLACEBO [J].
PAULUS, HE ;
EGGER, MJ ;
WARD, JR ;
WILLIAMS, HJ .
ARTHRITIS AND RHEUMATISM, 1990, 33 (04) :477-484
[22]  
RITCHIE DM, 1968, Q J MED, V37, P393
[23]  
ROPES M W, 1958, Bull Rheum Dis, V9, P175
[24]   PLASMA-LEVELS OF THE LEUKOCYTE L1-PROTEIN IN FEBRILE CONDITIONS - RELATION TO ETIOLOGY, NUMBER OF LEUKOCYTES IN BLOOD, BLOOD SEDIMENTATION REACTION AND C-REACTIVE PROTEIN [J].
SANDER, J ;
FAGERHOL, MK ;
BAKKEN, JS ;
DALE, I .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1984, 44 (04) :357-362
[25]  
SCHUMACHER HR, 1988, PRIMER RHEUMATIC DIS, P84
[26]   CARDIAC-SURGERY AND DISTRIBUTION OF THE LEUKOCYTE L1 PROTEIN-CALPROTECTIN [J].
SEMB, AG ;
GABRIELSEN, TO ;
HALSTENSEN, TS ;
FAGERHOL, MK ;
BRANDTZAEG, P ;
VAAGE, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1991, 5 (07) :363-367
[27]   ANTIMICROBIAL ACTIONS OF CALCIUM-BINDING LEUKOCYTE L1 PROTEIN, CALPROTECTIN [J].
STEINBAKK, M ;
NAESSANDRESEN, CF ;
LINGAAS, E ;
DALE, I ;
BRANDTZAEG, P ;
FAGERHOL, MK .
LANCET, 1990, 336 (8718) :763-765
[28]   THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS [J].
STEINBROCKER, O ;
TRAEGER, CH ;
BATTERMAN, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 140 (08) :659-662
[29]   COMPARISON OF AURANOFIN, GOLD SODIUM THIOMALATE, AND PLACEBO IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - A CONTROLLED CLINICAL-TRIAL [J].
WARD, JR ;
WILLIAMS, HJ ;
EGGER, MJ ;
READING, JC ;
BOYCE, E ;
ALTZSMITH, M ;
SAMUELSON, CO ;
WILLKENS, RF ;
SOLSKY, MA ;
HAYES, SP ;
BLOCKA, KL ;
WEINSTEIN, A ;
MEENAN, RF ;
GUTTADAURIA, M ;
KAPLAN, SB ;
KLIPPEL, J .
ARTHRITIS AND RHEUMATISM, 1983, 26 (11) :1303-1315
[30]  
WEBB J, 1973, Scandinavian Journal of Rheumatology, V2, P127